Figure 3 | Scientific Reports

Figure 3

From: A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era

Figure 3

Survival outcomes by prognostic scoring. (a) Prognostic scoring without inclusion of first-line treatment data, revealing 3 groups of patients derived from point-wise addition of each adverse factor for OS. (b) Overall survival outcomes by prognostic scoring using Clinico-Genotypic Index (CGI), revealing 4 groups of patients derived from point-wise addition of each independent adverse factor with incorporation of treatment data. Higher number of points on both scoring indices significantly predicted for poorer OS (p < 0.001).

Back to article page